Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ESLA

Estrella Immunopharma Inc

May 22 • 04:00PM ET

1.16

+0.03 2.65 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: CUE BLRX INAB NVCT IMNN

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.35	Insider Own	60.61%	Shs Outstand	42.67M	Perf Week	4.50%
Market Cap	49.92M	Forward P/E	-	EPS next Y	-	Insider Trans	0.01%	Shs Float	16.95M	Perf Month	-32.16%
Enterprise Value	47.99M	PEG	-	EPS next Q	-	Inst Own	12.15%	Short Float	0.87%	Perf Quarter	-3.33%
Income	-13.25M	P/S	-	EPS this Y	-	Inst Trans	0.32%	Short Ratio	1.75	Perf Half Y	-33.71%
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-434.36%	Short Interest	0.15M	Perf YTD	-25.64%
Book/sh	-0.12	P/C	25.87	EPS next 5Y	-	ROE	-314.60%	52W High	3.15 -63.17%	Perf Year	16.00%
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	-27.10% -70.08%	ROIC	-	52W Low	0.78 48.72%	Perf 3Y	-89.39%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.39% 9.00%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-22.50%	Oper. Margin	-	ATR (14)	0.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.24	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.86	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.24	EPS Q/Q	6.53%	SMA20	-12.09%	Beta	0.92	Target Price	12.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-15.36%	Rel Volume	0.33	Prev Close	1.13
Employees	-	LT Debt/Eq	-	Earnings	Feb 25	SMA200	-18.47%	Avg Volume	84.52K	Price	1.16
IPO	Sep 14, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	22.22% -	Trades		Volume	27,921	Change	2.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)